Kostas Haveles

Kostas Haveles is currently the Managing Director at Optimapharm and Qualitis SA, with extensive experience in clinical trials supervision and general management. Prior to their current roles, Kostas held positions at CORONIS Research SA and GlaxoSmithKline, focusing on clinical trials monitoring and regulatory submissions. With a background in basic research in Molecular Radiation Biology, Kostas obtained their PhD from NCSR Demokritos and a BSc in Physics from the University of Athens.